AU2356301A - Silylated heterocyclic compounds - Google Patents

Silylated heterocyclic compounds

Info

Publication number
AU2356301A
AU2356301A AU23563/01A AU2356301A AU2356301A AU 2356301 A AU2356301 A AU 2356301A AU 23563/01 A AU23563/01 A AU 23563/01A AU 2356301 A AU2356301 A AU 2356301A AU 2356301 A AU2356301 A AU 2356301A
Authority
AU
Australia
Prior art keywords
heterocyclic compounds
silylated heterocyclic
silylated
compounds
heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23563/01A
Inventor
Joachim Nozulak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2356301A publication Critical patent/AU2356301A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU23563/01A 1999-11-15 2000-11-13 Silylated heterocyclic compounds Abandoned AU2356301A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19954847 1999-11-15
DE19954847 1999-11-15
PCT/EP2000/011203 WO2001036428A1 (en) 1999-11-15 2000-11-13 Silylated heterocyclic compounds

Publications (1)

Publication Number Publication Date
AU2356301A true AU2356301A (en) 2001-05-30

Family

ID=7929072

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23563/01A Abandoned AU2356301A (en) 1999-11-15 2000-11-13 Silylated heterocyclic compounds

Country Status (6)

Country Link
AR (1) AR026451A1 (en)
AU (1) AU2356301A (en)
CO (1) CO5261532A1 (en)
EC (1) ECSP003761A (en)
PE (1) PE20011023A1 (en)
WO (1) WO2001036428A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA50800A (en) 2017-11-24 2020-09-30 H Lundbeck As NEW CATECHOLAMINE MEDICINAL PRODUCTS FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE
US11104697B2 (en) 2019-05-20 2021-08-31 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11111263B2 (en) 2019-05-20 2021-09-07 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11130775B2 (en) 2019-05-20 2021-09-28 H. Lundbeck A/S Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11168056B2 (en) 2019-05-20 2021-11-09 H. Lundbeck A/S Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2689892A1 (en) * 1992-04-09 1993-10-15 Rhone Poulenc Rorer Sa New 4-substd. 1,4-di:phenyl-1-sila:cyclopentane derivs. - used as serotonin antagonists e.g. for treating anxiety, migraine, asthma or hypertension
US6210705B1 (en) * 1997-12-15 2001-04-03 Noven Pharmaceuticals, Nc. Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate

Also Published As

Publication number Publication date
AR026451A1 (en) 2003-02-12
WO2001036428A1 (en) 2001-05-25
ECSP003761A (en) 2002-06-26
CO5261532A1 (en) 2003-03-31
PE20011023A1 (en) 2001-09-27

Similar Documents

Publication Publication Date Title
AU5413600A (en) Compounds
AU1978699A (en) Heterocyclic compounds
AU1278701A (en) Novel compounds
GB9929973D0 (en) Heterocyclic compounds
AU2408300A (en) Novel compounds
AU1746401A (en) Compounds
AU6032100A (en) New compounds
AU3997700A (en) Anti-first-pass effect compounds
AU2001258841A1 (en) Heterocyclic compounds
AUPP921299A0 (en) New heterocyclic compounds
AU4132200A (en) Novel compounds
AU2356301A (en) Silylated heterocyclic compounds
AU5887400A (en) Derivative compounds
AU2663100A (en) Substituted aryl heterocyclic compounds
AU3324700A (en) Imidazole compounds
AU2109700A (en) Novel compounds
AU7961800A (en) Thiazolidinedione derivatives
AU3730699A (en) Heterocyclic compound
AU5119400A (en) Compounds
AU2288900A (en) Novel compounds
AU5251200A (en) Novel imidazole derivatives
AU6168900A (en) Compounds
AU2668000A (en) Bis-styrylbiphenyl compounds
AU1385701A (en) Novel compounds
AU7784700A (en) Novel compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase